Clinical Trials Sponsored by National Institute of Chemistry, Slovenia

Total 26578 results

National Eye Institute (NEI)

Completed

People s Expectations When Enrolling in a Phase I/II RS1 Ocular Gene Transfer Clinical Trial

Retinoschisis | X-Linked

United States
National Cancer Institute (NCI)

Terminated

Enzastaurin to Treat Recurrent Brain Tumor

Glioma

United States
National Cancer Institute (NCI)

Completed

Safety of Batracylin in Patients With Solid Tumors and Lymphomas

Neoplasms

United States
National Eye Institute (NEI)

Completed

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Macular Degeneration

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Ovarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
National Cancer Institute (NCI)

Terminated

Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

Mesothelioma

United States
National Cancer Institute (NCI)

Completed

Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Terminated

Biomarker Analysis of Central Nervous System Tumors

Central Nervous System Neoplasms | Brain Cancer | Neoplasms, Brain | Primary Brain Neoplasms | Cancer of the Brain

United States
National Cancer Institute (NCI)

Completed

EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

Gastric Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Predictors of Cardiovascular Disease

Cardiovascular Disease

United States
National Cancer Institute (NCI)

Terminated

Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer

Prostate Cancer

United States
National Eye Institute (NEI)

Terminated

Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)

Inherited Retinal Degeneration | Inherited Ophthalmic Diseases

United States
Creighton University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women (CAPS)

Cancer

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Sarcoma | Wilms' Tumor | Refractory Cancer | Adenaocortical Carcinoma | Coldrhood Cancer

United States
National Cancer Institute (NCI)

Completed

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

Pancreatic Neoplasms | Mesothelioma | Adenocarcinoma of Lung

United States
National Cancer Institute (NCI)

Completed

Cancer Symptom Data From Multiple Treatment Centers

Breast Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy

Brain Neoplasms | Brain Cancer

United States
National Cancer Institute (NCI)

Completed

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Colorectal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Internet Support Group for Parents of a Child With Neurofibromatosis Type 1

Neurofibromatosis 1

United States
National Cancer Institute (NCI)

Terminated

Modified White Blood Cells That Secrete IL-2 and Express a Protein That Targets the ESO-1tumor Protein for Metastatic Cancer

Metastatic Cancer | Metastatic Melanoma | Metastatic Renal Cancer

United States
National Cancer Institute (NCI)

Terminated

Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

Lymphoma | Leukemia | Myeloproliferative Disorders | Myelodysplastic Syndrome | Multiple Myleoma

United States
National Cancer Institute (NCI)

Withdrawn

Providing Access to Cord Blood Units for Transplants

Multiple Myeloma | Non-Hodgkin Lymphoma | Acute Leukemias | Chronic Myelogous Leukemia/Other Leukemia | MDS/MPS
National Cancer Institute (NCI)

Terminated

Evaluation of Molecular Markers in Adrenal Tumors

Adrenal Gland Neoplasms

United States
National Cancer Institute (NCI)

Completed

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

Cervical Intraepithelial Neoplasia

United States
National Cancer Institute (NCI)

Completed

An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas

Neoplasms | Lymphoma

United States
National Cancer Institute (NCI)

Terminated

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Ocular Melanoma

Metastatic Uveal Melanoma | Metastatic Ocular Melanoma

United States
National Cancer Institute (NCI)

Completed

Satraplatin and Prednisone to Treat Prostate Cancer

Prostate Cancer | Genetic Polymorphism

United States
National Cancer Institute (NCI)

Completed

Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas

Lymphoma | Neoplasm

United States
National Eye Institute (NEI)

Terminated

Study of Retinal Findings in People With Signs and Symptoms of Alzheimer s Disease Enrolled in 09-M-0198

Age-Related Macular Degeneration | AMD | Alzheiner's Disease

United States
National Cancer Institute (NCI)

Completed

Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease

Chronic Graft-Versus-Host-Disease

United States
National Cancer Institute (NCI)

Completed

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Terminated

(11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas

Glioblastoma Multiforme | Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic Oligodendroglioma | Low Grade Glioma

United States
National Cancer Institute (NCI)

Completed

Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers

Neoplasms

United States
National Cancer Institute (NCI)

Completed

GW572016 to Treat Recurrent Malignant Brain Tumors

Glioma | Brain Tumor | Glioblastoma Multiforme | Gliosarcoma | GBM | GS

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases

Neoplasms | Liver Metastases

United States
National Cancer Institute (NCI)

Terminated

Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor Removal

Melanoma | Sarcoma | Pleural Malignancy | Epithelial Malignancies

United States
National Cancer Institute (NCI)

Terminated

Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Non-Hodgkins Lymphoma | Hodgkins Lymphoma

United States
National Cancer Institute (NCI)

Completed

Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer

Prostatic Neoplasms

United States
National Cancer Institute (NCI)

Completed

R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas

Neurofibroma, Plexiform | Neurofibromatosis Type I

United States, Germany
National Cancer Institute (NCI)

Completed

Self-Affirmation and Response to Health Risk Information

Alcohol Drinking | Emotions | Ego

United States
National Cancer Institute (NCI)

Completed

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Terminated

Thyroid Abnormalities Associated With Exposure to Atmospheric Emissions of Radioactive Iodine

Thyroid Abnormalities

United States
National Eye Institute (NEI)

Completed

Molecular Genetics of Retinal Degenerations

Retinal Degeneration | Retinitis Pigmentosa

United States, India, Pakistan, China
National Cancer Institute (NCI)

Completed

Genetic Susceptibility to Factor VIII Inhibitors

Hemophilia

Sweden
National Eye Institute (NEI)

Terminated

Genetic Factors in Age-Related Macular Degeneration

Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Multiple Myeloma

United States
National Cancer Institute (NCI)

Terminated

p53 Vaccine for Ovarian Cancer

Ovarian Neoplasm

United States
National Eye Institute (NEI)

Completed

Color Vision as a Measure for Inherited Retinal Diseases

Healthy Volunteer | Retinal Disease | Inherited Retinal Degeneration

United States

Clinical Trials Sponsored by National Institute of Chemistry, Slovenia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations